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ABSTRACT 
By using a combined technique of immunocytochemistry and 13H]thymi- 
dine autoradicgraphy, we have determined the "birth date" of opioid pep- 
tide-containing neurons in several hypothalamic nuclei and regions. These 
include proopiomelanocortin (POMC) neurons (represented by ACTH immu- 
noreactivity) in the arcuate nucleus; dynorphin A neurons in the supraoptic 
and paraventrjcular nuclei and the lateral hypothalamic area; and leu- 
enkephalin neurons in the periventricular, ventromedial, and medial mam- 
millary nuclei, 3s well as in preoptic and perifornical areas. Arcuate POMC 
neurons were born very early in embrymic development, with peak heavy 
[3H]thymidine nuclear labelling occurring on embryonic day E12. Supraop- 
tic and paraventricular dynorphin A neurons were also labelled relatively 
early (peak at E13). The lateral hypothalamic dynorphin A neurons showed 
peak heavy labelling also on day E12. By contrast, leu-enkephalin neurons 
in the periventricular nucleus and medial preoptic area exhibited peak 
heavy nuclear labeiling on day E14. Furthermore, perifornical and ventro- 
medial leu-enkephalin neurons were also born relatively early (peak on days 
E l2  and E13, respectively). However, the leu-enkephalin neurons in the 
medial mammillary nucleus were born the latest of all cell groups studied 
(i.e., peak at E15). The results indicate a differential genesis of these opioid 
peptide-containing neuronal groups in different hypothalamic nuclei and 
regions. 
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autoradiography 
The existence of neuropeptides and neurotransmitters in 
the brain during early ontogenetic development has raised 
critical questions regarding the role of these substances in 
brain maturation as well as their functional capacity in the 
course of development (Coyle, '77; Lauder and Krebs, '78; 
Khachaturian and Sladek, '80; Swaab and Ter Borg, '81). 
For example, the presence of monoamines in embryonic 
brain prior to the establishment of synaptic neurotransmis- 
sion has raised the possibility that these substances might 
act as neurotrophic agents in early ontogenesis (Olson and 
Seiger, '72; Seiger and Olson, '73), perhaps by regulating 
the onset of differentiation of cells in their projection areas 
CLauder and Bloom '74; Lauder and Krebs, '76). Likewise, 
a-melanocyte-stimulating hormone ((r-MSH), a peptide de- 
rived from proopiomelanocortin (POMC), has been shown 
to stimulate brain development during late gestational pe- 
riods (Swaab and Martin, '81). 
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The development and role of opioid and related peptides 
in brain processes during ontogenesis have only just begun 
to be addressed (Bayon et  al., '79; Pickel et al., '82; Palmer 
et al., '82; Khachaturian et al., '83a; Alessi et al., '83; Alessi 
and Khachaturian, '85; Daikoku et  al., '83; Schwartzberg 
and Nakane, '82). Biochemical studies of dissected regions 
have been useful in providing quantitative measures of 
opioid peptide content and form in different brain regions 
during maturation (Bayonet al., '79; Patey et al., '80; Alessi 
et al., '83; Alessi and Khachaturian, '85; Wardlaw and 
Frantz, '83). However, such studies are obviously limited in 
accurately pinpointing the location of neuronal cell bodies 
and their projections. Immunohistochemical studies have 
been successful in determining the location and matura- 
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hyde at a pressure of 140 mm Hg. The brain was then 
removed and postfixed for a n  additional hour at 4"C, stored 
in 15% sucrose overnight at 4"C, and frozen in O.C.T. (Tis- 
sue Tek) embedding medium in liquid nitrogen. All tissues 
were stored at -80°C prior to use. Brains were sectioned in 
a cryostat at -20°C and thaw-mounted onto gelatin-coated 
slides. 
Immunocytochemistry 
The antisera used in the present study have been exten- 
sively characterized, each being highly specific for the cor- 
responding peptide (Watson et al., '78; Khachaturian et al., 
'82, '83b). The adrenocorticotrophic hormone (ACTH) anti- 
serum specific for ACTH (20-24) can be blocked by ACTH 
(1-24), 41-39), 411-24), but not by ACTH (ll-lg), a-MSH, 
P-lipotropin, 0-endorphin, or met-enkephalin. The anti-leu- 
enkephalin serum can be blocked by leu-enkephalin, but 
not by BAM-22P, peptide E, dynorphin A (1-17), or @-endor- 
phin. Lastly, the anti-dynorphin A (1-17) serum can be 
blocked by dynorphin A (1-17) and dynorphin A (14,  but 
not by dynorphin B (1-13), a-neo-endorphin, leu-enke- 
phalin, met-enkephalin, BAM-22P, peptide E, or &en- 
dorphin. 
For immunocytochemistry (Khachaturian et al., '821, 
slide-mounted tissues were allowed to air-dry at  room tem- 
perature, after which they were incubated (37°C) with pri- 
mary antiserum. All antisera were diluted with 0.02 M 
phosphate-buffered saline (PBS) in 0.3% triton X-100. After 
1-hour incubation, the slides were transferred to moist- 
boxes and stored for 24 hours at 4°C. The second day, all 
tissues were washed in PBS and incubated (37°C) for 30 
minutes with goat antirabbit serum (Arnel). The slides 
were again stored for 24 hours at 4°C. The third day, all 
tissues were washed in PBS and incubated for successive 
40-minute periods (with PBS wash in between) with anti- 
horseradish-peroxidase (anti-HRP) serum, followed by 4 pg/ 
rnl HRP enzyme (Sigma, type VI). After PBS wash, the 
slide-mounted sections were treated with diaminobenzidine 
(Sigma) (0.125 mg/ml) in a solution of 0.03%' H202 for 15 
minutes at room temperature. The slides were washed in 
distilled water and allowed to air dry. 
[3H]thymidine autoradiography 
For [3H]thymidine autoradiography (Langager et  al., '82), 
the air-dried slide-mounted tissues (from the previous step) 
were individually dipped into a subbing solution made of 5 
mg/ml gelatin and 0.5 mg/ml chromium potassium sulfate 
and allowed to air-dry. Next, the dry sections were dipped 
into a solution of 0.01 g/ml 2,5-diphenoxazole (PPO) in 95% 
ethanol and allowed to air-dry once more. The slides 
were then transferred to a darkroom equipped with a 
Thomas Super Safelight, individually dipped into Kodak 
NTB-2 emulsion (at 41"C), and allowed to air-dry upright 
for 2 hours in complete darkness. The slides were stored in 
light-tight slide boxes containing Drierite at -80°C for 1 
week, after which the slides were developed in Kodak D-19 
developer at 16-17"C, fixed in Kodak Rapidfix, and washed 
in distilled water. The sections were dehydrated through 
graded ethanols and xylenes and coverslipped in Permount. 
Cell counts 
With a Leitz Orthoplan microscope, immunoreactive cells 
in a specific hypothalamic nucleus were counted in several 
sections. The nuclear boundaries were determined using 
adjacent Nissl-stained sections. Immunoreactive ACTH- 
tional patterns of identified opioid neurons in different re- 
gions of the central nervous system (Pickel et  al., '82; 
Khachaturian et  al., 83a). Nevertheless, both anatomical 
and biochemical studies suffer from the limitations of the 
techniques used for detection of minute quantities of pep- 
tide. Thus, it  is conceivable that at an  early maturational 
stage, peptide synthesis occurs at such low rates that  pep- 
tide content might fall below the sensitivity of the anti. 
serum used in radioimmunoassay or immunocytochemistry. 
However, the time of neuron genesis, whereby through a 
final mitotic division a neuroblast is formed and begins to 
differentiate into a neuron, can be determined by using a 
['Hlthymidine autoradiographic technique (see Sidman, 
'70). This technique accurately determines the time during 
gestation when a particular group of neurons is born, and 
has been used to study the time of origin of hypothalamic 
neurons (Ifft, '72; Shimada and Nakamura, '73; Altman 
and Bayer, '78a). Still, this "birth-dating" technique cannot 
account for the chemical identity of the neurons in ques- 
tion. In order to determine the chemical identity of specific 
neurons, Hoffman et  al. ('80) combined [3H]thymidine au- 
toradiography with immunocytochemistry to investigate 
the time or origin of somatostatin-containing neurons in 
the hypothalamus. In the present study, we have employed 
a similar immunocytochemical-autoradiographic technique 
to determine the time of genesis of opioid peptide-contain- 
ing neurons in several hypothalamic nuclei (Khachaturian 
et al., '85). 
MATERIALS AND METHODS 
Adult male and female Sprague-Dawley rats were used 
in these experiments. At least 24 hours prior to mating, 
male rats were placed in large individual cages (one rat  per 
cage) and kept under normal conditions. Three female rats 
were placed in each cage containing a male, before 6 P.M. 
A t  8 A.M. the following day, vaginal smears were obtained 
from each of the females and examined under a microscope 
for live sperm. The presence of sperm was considered as 
indicative of conception, and that day was considered day 
zero of gestation (Khachaturian and Sladek, '80). The im- 
pregnated females were then placed in individual cages and 
also kept under normal conditions. Embryonic development 
was allowed to progess until day 12, 13, 14, 15, or 16 of 
gestation at which time three or more pregnant rats were 
selected at each particular gestational day for ["]thymi- 
dine injection. At each embryonic day, E l2  through E16, 
rats were injected with 7 pCilg body weight of [3H]thymi- 
dine (New England Nuclear) at a concentration of 1 mCi/ 
mi (specific activity 6.7 Cilmmol). Each rat received only 
one injection. Injected rats were returned to individually 
marked cages and kept under normal conditions. These rats 
were allowed to deliver, and the progeny to develop into 
young adults (approximately 6 weeks). 
Three or more adult males were selected from each [3H] 
thymidine injection group (i.e., day E l2  through E16), and 
each rat was anesthetized with sodium pentobarbital and 
injected intracerebroventricularly with 50-200 pg/lO pl of 
colchicine to enhance immunocytochemical visualization of 
neuronal perikarya. At 24-48 hours after colchicine admin- 
istration, each animal was anthesthetized by intraperi- 
toneal injection of sodium pentobarbital, and the car- 
diovascular system was flushed with 50 ml ice-cold 0.9%. 
saline injected through the left ventricle. This was imme- 
diately followed by intraaortic perfusion for 30 minutes 
with ice-cold phosphate-buffered (pH 7.4) 4% paraformalde- 
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containing perikarya were counted in the arcuate nucleus 
(Fig. 1A). Dynorphin A immunoreactive perikarya were 
counted in the magnocellular supraoptic (Fig. 1B) and par- 
aventricular nuclei, as were those scattered in the lateral 
hypothalamic area. Immunoreactive leu-enkephalinergic 
neuronal perikarya were counted in the periventricular 
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nucleus (Fig. 1 0 ,  ventromedial nucleus, medial mammil- 
lary nucleus, and other scattered cells in the preoptic area, 
as well as the perifornical region in the lateral hypotha- 
lamic area. The counted cells were divided into two cate- 
gories: heavy or medium labelled (H/M: approximately 15 
or more grains per nucleus), and light or unlabelled CKJ: 
approximately 0-10 grains per nucleus), according to the 
density of silver grains over the cell nucleus (see Fig. 1). 
Only those immunoreactive perikarya that had a well-de- 
fined nucleus were included in the counts. The results were 
expressed as percentages of WM-labelled immunoreactive 
cells compared to the total number of immunoreactive cells 
(i.e., [WM + H/M + L/u] x 100) in each particular nucleus 
or area. These calculated values represented the percentage 
of [3Hlthymidine-labelled immunoreactive cells at any 
given gestational day E12-E16. Since only those cells 
undergoing their final mitotic division exhibit H/M label- 
ling, this method of calculation indicates the percentage of 
all immunoreactive cells which originated (i.e., were “born”) 
on the day of t3H]thymidine injection. All slides were coded 
prior to counting to eliminate experimental bias. The statis- 
tical significance of changes in the percentage of cells incor- 
porating [3H]thymidine, across days, was evaluated by 
analysis of variance. Values of F corresponding to p values 
of less than .05 were taken to indicate statistical sig- 
nificance. 
Fig. 1. Representative hypothalamic nuclei from each opioid peptide- 
containing cell group under investigation. A. ACTH immunoreactive peri- 
karya in the arcuate nucleus. B. Dynorphin A immunoreactive perikarya 
in the supraoptic nucleus. C. Leu-enkephalin immunoreactive perikarya in 
the periventricular nucleus. Note that in each case the immunoreactive 
perikarya are slightly below the plane of focus in order to focus on the [’HI- 
thymidine autoradiographic grains in the overlying emulsion. Note also the 
presence of autoradiographic grains over the nucleus of both “stained” and 
“unstained” perikarya. The grain density over the stained neurons IS cate- 
gorized as heavy or medium (WMI and light or unlabelled (LN). Magnifi- 
cation: 362 x 
RESULTS 
In the adult brain, neuronal perikarya immunoreactive 
for ACTH, dynorphin A, and leu-enkephalin were noted in 
several hypothalamic and preoptic nuclei and areas. ACTH 
immunoreactive neurons were located within the arcuate 
nucleus and periarcuate region in the medial-basal hypo- 
thalamus (Fig. 1A). Dynorphin A immunoreactivity was 
seen in magnocellular supraoptic (Fig. 1B) and paraventri- 
cular perikarya as well as scattered neurons in the lateral 
hypothalamic area. Leu-enkephalin perikarya were local- 
ized to several hypothalamic nuclei, including the periven- 
tricular (Fig. lC), ventromedial, and medial mammillary 
nuclei, and scattered in the perifornical region at the level 
of the paraventricular nucleus, as well as in the medial pre- 
optic area. 
[3H]thymidine labelling appeared in the form of autora- 
diographic grains over the nuclei of immunoreactive neu- 
rons as well as other nonimmunoreactive neurons (see Fig. 
1). However, only immunoreactive neurons with distinct 
rounded nuclei with or without labelling were included in 
the data collection. Autoradiographic analyses of immuno- 
reactive neurons in the hypothalami of rats exposed in 
utero to [3H]thymidine at embryonic days E12, E13, E14, 
E15, or El6 revealed the following results: 
The ACTH-containing neurons of the arcuate nucleus 
showed a heavy nuclear-labelling pattern at very early 
stages of development (Fig. 2). More than 50% of ACTH 
immunoreactive cells incorporated H/M label on days El2 
and E13. From El4 through E16, a gradual drop in nuclear 
labelling occurred, with very low levels seen at E16. 
Among the three groups of dynorphinergic neurons, the 
patterns of labelling in the supraoptic and paraventricular 
nuclei appeared to be similar; i.e., in both nuclei, the dynor- 
phin A immunoreactive magnocellular neurons exhibited 
peak heavy labelling with [3Hlthymidine on embryonic day 
El3 (Figs. 3, 4). By day E14, the majority of cells (more 
than 80%) were already born, with minimal labelling occur- 
ring at days El5 and E16. In contrast, the immunoreactive 
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Fig. 2. Time course of ACTH (POMC) neuron genesis in the arcuate 
nucleus. Note heavy ['Hlthymidine labelling (% cells born) on days E12- 
E14. N = 2,266. Mean k S.E.M. In this and subsequent figures. prohahility 
( p )  values were determined by analysis of variance of percentages across 
days, while N indicates the total number of immunoreactive cells counted. 
Embryonir Day 
Fig. 3. Time course of dynorphin A neuron genesis in the supraoptic 
nucleus. Note peak heavy labelling of ['Hlthymidine (9% cells born) on day 
E13. N = 1,345. Mean f S.E.M. 
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Fig. 4 .  Time course of genesis of dynorphin A neurons in the paraven- 
tricular nucleus. Note that the pattern of cell birth in this nucleus corre- 
sponds closely to the pattern observed for the supraoptic nucleus. N = 
1,505. Mean f S.E.M. 
Fig. 5. Time course of dynorphin A neuron genesis in the lateral hypo- 
thalamic area. These neurons are  born relatively early as indicated by 
heavy [3H]thymidine labelling (% cells born) on days El2 and E13, respec- 
tively. N = 1,197. Mean f S.E.M. 
dynorphin perikarya in the lateral hypothalamus demon- 
strated a labelling pattern similar to that of arcuate ACTH 
neurons, with the heaviest nuclear [3H]thymidine label- 
ling occurring on days El2 and El3 (more than 50%) Fig.  5). 
A gradual decline in labelling was similarly noted between 
days El4 and El6 (no labelling at E16). 
Leu-enkephalin-containing neurons scattered in five sep- 
arate nuclei or regions exhibited diverse [3H]thymidine- 
labelling patterns of their nuclei. In the periventricular 
nucleus, enkephalinergic perikarya exhibited peak heavy 
labelling on embryonic day El4 (approximately 25%), with 
the majority of the remainder of labelling occurring on days 
El2 and El3 (approximately 25%) (Fig. 6). Very little label 
was detected on days El5 and E16. Enkephalin-containing 
neurons of the ventromedial nucleus were labelled most 
heavily on day El3 (approximately 24%), with the majority 
of the remainder of labelling occurring on embryonic days 
El4 and El5 (over 35%) (Fig. 7). In the medial mammillary 
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Fig. 6. Time course of leu-enke halin neuron genesis in the periventric- 
ular nucleus. Note peak heavy [ P Hlthymidine labelling (5% cells born) on 
day E14. N = 967. Mean f S.E.M. 
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Fig. 7. Time course of genesis of leu-enkephalin neurons in the ventro- 
medial nucleus. Note that while peak heavy ['Hlthymidine labelling (92 
cells born) is on day E13, significant labelling is also seen on days E12, E14, 
and E15. N = 718. Mean f S.E.M. 
Fig. 9. Time course of genesis of leu-enkephalin neurons in the perifor- 
nical hypothalamic area. Note the sharp decline in ["Hlthymidine labelling 
(% cells born) from El2 through E14, with zero labelling on the subsequent 
days studied N = 557. Mean S.E.M. 
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Fig. 8. Time course of leu-enkephalin neuron genesis in the medial mam- 
millary nucleus. Note peak heavy ['Hjthymidine labelling (% cells born) on 
day E l5  with minimal labelling on days ElZE14.  N = 847. Mean + S.E.M. 
nucleus, the enkephalin perikarya exhibited the most un- 
usual labelling pattern of all the groups studied. In this 
nucleus, the majority of immunoreactive enkephalinergic 
neurons were heavily labelled on days E14-El6 (approxi- 
mately 38%), with peak heavy labelling occurring on El5 
(Fig. 8). Minimal heavy labelling was seen on days El2 and 
E13. Enkephalin-containing perikarya scattered in the peri- 
fornical region showed a dramatic decline of heavy label- 
ling following day El2 (approximately 17%) (Fig. 9). All of 
the remainder of labelling occurred on days E l 3  and E14, 
with no labelling noted on days E l5  and E16. Lastly, in the 
medial preoptic area, scattered immunoreactive enkephali- 
nergic neurons exhibited peak heavy labelling on day El4 
(approximately 23%) with gradually declining heavy label- 
ling seen both before and after that day (Fig. 10). Still, the 
majority of heavy labelling in this region occurred between 
E l3  and E l5  (over 35%). 
DISCUSSION 
In the present study, we have investigated the develop- 
ment of opioid peptidergic neurons in the rat hypothala- 
mus. These neurons are represented by ACTH, dynorphin 
A, and leu-enkephalin immunoreactivity localized to neu- 
ronal perikarya of colchicine-pretreated young adult ani- 
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Fig. 10. Time course of leu-enkephalin neuron genesis in the medial 
preoptic area. Note peak heavy [?HH]thymidine labelling (%, cells born) on 
day E14. N = 1,343. Mean ? S.E.M. 
mals. These three immunoreactivities are markers for the 
three separate opioid precursors present in neural tissue 
(Nakanishi et al., '79; Comb et al., '82; Noda et al., '82; 
Gubler et al., '82; Kakidani et al., '82). The distribution of 
peptides derived from these precursors has been studied 
extensively in the central nervous system. These include 
POMC-derived peptides (Watson et al., '78a,b; Bloch et al., 
'78; Bloom et al., '78; Zimmerman et al., '78; Nilaver et al., 
'79; O'Donohue et al., '79; Finley et al., '81; Khachaturian 
et al., '85), proenkephalin-derived peptides (Elde et al., '76; 
Watson et al., '77, '82b; Hokfelt et al., '77; Sar et al., '78; 
Khachaturian et al., '83b,c), and prodynorphin-derived pep- 
tides (Waston et al., '81, '82a,b, '83; Khachaturian et al., '82; 
Vincent et al., '82; Weber et al., '82). The antisera used in 
the present study have been extensively characterized else- 
where (Watson et al., '78b; Khachaturian et al., '82, '83b). 
In order to determine the onset of neuron differentiation, 
the animals in this study were exposed in utero to a brief 
pulse of [3H]thymidine on specific days during the embry- 
onic period. According to Sidman ('70), t3H]thymidine given 
as a pulse injection is incorporated within 20-40 minutes 
into cell nuclei. In the present study, the [3H]thymidine- 
exposed rats were allowed to develop into young adults, so 
that the neurons in question would be mature, hypotha- 
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lamic nuclear boundaries well defined, and the animal could 
reliably be treated with colchicine to enhance perikaryal 
immunoreactivity. This treatment greatly enhances the re- 
liability of the cell counts, since without colchicine admin- 
istration, perikaryal immunoreactivity is not as pronounced 
with every antiserum used. 
Some of the observed patterns of cell birth seen in the 
present study show good correspondence with other studies 
of the ontogeny of opioid peptides, while others do not. For 
example, the observation here that ACTH-containing neu- 
rons exhibit heaviest labelling in the earliest gestational 
period studied (E12-El3) agrees well with the detection of 
immunoreactive ACTH, (?-endorphin, and other POMC 
products early in embryonic development. We and other 
investigators have noted immunoreactive POMC cells in 
the medial-basal hypothalamus as early as embryonic day 
El2 (Schwartzberg and Nakane, '82; Khachaturian et al., 
'83a) or E13.5 (Daikoku et  al., '83). While the methods for 
determining the age of the embryos vary slightly among 
the latter studies, nevertheless, there is good consensus 
that POMC neurons are among the earliest arising of the 
opioid peptide neurons. 
Dynorphin-containing magnocellular neurons are not de- 
tectable with immunocytochemistry until gestational day 
El8 (Khachaturian et al., '83a). Dynorphin neuronal peri- 
karya first appear in the region of the supraoptic nucleus 
during late gestation. However, we have been able to detect 
dynorphin A immunoreactive fibers in the neural lobe of 
,the pituitary at day E17. The presence of immunoreactivity 
in the neural lobe alone would argue for the synthesis of 
dynorphin in magnocellular neurons at  an even earlier 
gestational day (i.e., prior to E17). That magnocellular neu- 
rons are biosynthetically active at this stage of develop- 
ment has also been demonstrated by studies showing 
neurophysin immunoreactivity as early as day E l 4  of ges- 
tation (Sinding et al., '80). Nevertheless, the observed im- 
munoreactivity does not correspond well with the present 
autoradiographic determination of the time of origin of 
these neurons (E12-El4). This can perhaps be explained by 
a time lag between neuron birth and the initiation of neu- 
ropeptide precursor synthesis, and also by the notion that 
peptide concentration at  such an early stage might be below 
the level of detection by immunocytochemistry. Generally, 
radioimmunoassay offers a more sensitive means for mea- 
suring minute quantities of peptide during early gestation. 
Such data are not yet available for dynorphin peptides. Still 
another consideration is the specificity of the antiserum 
used. It is conceivable that if the posttranslational process- 
ing mechanisms are immature, most if not all peptides 
synthesized at  an  early stage may be in precursor form 
such that they are not easily detected by the antibody (i.e., 
low antigenicity). Thus, as more and more cells are born 
and begin to mature, sufficient quantities of free peptide 
may become available for detection. In this context, it is 
interesting to note that even in the case of POMC neurons 
of the arcuate nucleus, the best observed immunoreactivity 
at  a very early gestational period (E12) is obtained using a 
16K antiserum (N-terminus of POMC precursor), with 
ACTH and 0-endorphin antisera showing less immunoreac- 
tivity, and with a-MSH antiserum showing no immunoreac- 
tivity at  all (Khachaturian et  al., '83a). Perhaps the use of 
dynorphin antisera directed against specific portions of the 
prodynorphin precursor will likewise enable its earlier de- 
tection in the embryo. Of course, the above arguments do 
not rule out the possibility that dynorphin synthesis in 
magnocellular neurons might begin late in gestation. These 
neurons also produce arginine-vasopressin (cf. Watson et 
al., '82a), a hormone which may be important at an earlier 
stage of development (see Swaab and Ter Borg, '81). 
The pattern of differentiation of leu-enkephalin-contain- 
ing neurons in the various hypothalamic and preoptic re- 
gions is also indicative of neuron birth several days prior to 
the detection of immunoreactivity. Here, clearly, neurons 
arise at  different stages of development in different nuclei. 
For example, immunoreactive leu-enkephalin neurons in 
the perifornical region and ventromedial nucleus arise early 
(E12-El4); those in the periventricular nucleus and medial 
preoptic area arise relatively later (E13-El5); while those 
neurons in the medial mammillary nucleus (E14-El6) arise 
the latest of all cell groups examined. By contrast, most 
immunocytochemical studies of enkephalin have described 
immunoreactive perikarya in the fetus at  gestational days 
E17-El8 (Pickel et al., '82; Palmer et al., '82; Khachaturian 
et al., '83a). Nevertheless, enkephalin fiber immunoreactiv- 
ity has been noted at E15-El6 in the three studies men- 
tioned above. These observations indicate biosynthesis of 
enkephalin at  an earlier stage, with perikaryal levels too 
low to be detected by immunocytochemistry. Similarly, en- 
kephalin immunoreactivity has been detected by radioim- 
munoassay at E16, the earliest gestational day studied so 
far (Bayon et al., '79). Again, as suggested for dynorphin, it 
is possible that there is a time lag between neuron birth 
and initiation of enkephalin synthesis. Moreover, enke- 
phalin at  an early embryonic stage might be present in 
precursor form, and thus not be as easily detectable with 
the present antiserum. In fact, most of the previous discus- 
sion pertaining to the genesis and differentiation of dynor- 
phin neurons might also apply to enkephalin neurons as 
well. Thus, the use of antisera raised against various spe- 
cific areas of the proenkephalin molecule might prove use- 
ful in the dectection of precursor forms at  earlier gestational 
days in concordance with the observed patterns of cell birth. 
Previous [3H]thymidine autoradiographic studies of hy- 
pothalamic nuclear development, utilizing Nissl-stained 
material, have demonstrated that there exist specific pat- 
terns that govern the generation of neurons in different 
zones within the hypothalamus (Ifft, '72; Altman and Bayer, 
'78a). Ifft ('72) has suggested that laterally placed neurons 
arise earlier than those situated in more medial nuclei. In 
addition to this lateral-to-medial gradient of hypothalamic 
neuron genesis, which apparently is contrary to patterns 
seen elsewhere in the brain (see Jacobson, '78; chapter 31, 
there also appears to be a dorsal-to-ventral gradient of 
neurogenesis (Ifft, '72). Based on their more comprehensive 
labelling studies, Altman and Bayer ('78a) have further 
refined these gradients of hypothalamic neuron birth into 
four chronologically different classes, within each of which 
neuron genesis appears to be isochronous. Of interest to us, 
for purposes of this paper, are class 1 (earliest arising) 
neurons in the lateral hypothalamic area, class 2 (early 
arising) neurons in the supraoptic and paraventricular nu- 
clei and medial preoptic area, and class 3 (late arising) 
neurons in the arcuate, ventromedial, periventricular, and 
medial mammillary nuclei (Altman and Bayer, '78a). We 
have observed no opioid peptide-containing neurons belong- 
ing to the latest-arising class 4 cells. In correlating the 
present findings to those of Altman and Bayer ('78a), it is 
important to note that the two studies have used different 
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methods of determining the embryonic age a t  which time 
[3H]thymidine was made available to the growing embryos. 
In the present study, day of coitus (i,e., detection of sperm 
in vaginal smear) has been designated day zero of gestation, 
while Altman and Bayer ('78b) have considered day of coi- 
tus as day l of gestation. Thus, E13-El7 of the latter study 
correspond to days E12-El6 used in the present study. For 
simplicity, we shall hereafter use E l2  through E l6  when 
referring to either study. Furthermore, when used, the des- 
ignation class 1-4 neurons will be in reference to the find- 
ings of Altman and Bayer ('78a). 
In general, we have noted a good correspondence between 
the present findings and those of Altman and Bayer ('78a) 
(Table 1). The earliest-arising lateral hypothalamic dynor- 
phin A neurons (56% at E12iE13) and perifornical leu-en- 
kephalin neurons (26% at E12/E13) fit into the class 1 
category. The early-arising magnocellular neurons in both 
the supraoptic (86% at E12-El4) and paraventricular (87% 
at E12-El4) nuclei can be designated as class 2 neurons. 
However, this correspondence is not a sharp one, perhaps 
since the present study deals only with vasopressin-dynor- 
phin-producing neurons (Watson et  al., '82a) and not oxyto- 
cin neurons. Whether there are differences in the birth 
patterns of vasopressin versus oxytocin neurons is cur- 
rently unknown. Other early-arising neurons observed in 
the present study include the leu-enkephalin neurons situ- 
ated in the medial preoptic area (45% at E12-El4) and 
periventricular nucleus (50%) at E12-E14), which accord- 
ingly fall into the class 2 category, The time of birth of 
periventricular neurons was not determined in the study of 
Altman and Bayer ('78a). 
In the late-arising category, mention should be made of 
leu-enkephalin neurons in the medial mammillary nucleus 
(38% at E14-El6) as well as the ventromedial nucleus (61% 
at E13-E15), corresponding to class 3 neurons. Once again, 
the exact patterns of labelling seen in the present study do 
not match precisely the patterns reported by Altman and 
Bayer ('78a). For example, in the ventromedial nucleus, 
peak heavy labelling of leu-enkephalin neurons occurs at 
E13. In contrast, Altman and Bayer ('78a) have differen- 
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tiated between ventral and dorsal regions of the ventrome- 
dial nucleus. Although the present study has not made that 
distinction, we believe that the patterns of leu-enkephalin 
cell birth in ventromedial nucleus match more closely with 
the class 3 neurons situated in the dorsal aspects of this 
nucleus. 
Lastly, the patterns of cell birth seen in the POMC cell 
group situated in the arcuate nucleus show a n  inverse 
correspondence with those of class 3 and 4 arcuate neurons, 
which are among the late and latest born in the hypothal- 
amus, respectively. By contrast, ACTH immunoreactive 
neurons in the arcuate nucleus were labelled heavily early 
and belong to the earhest-arising hypothalamic neurons 
(76% at E12-El4). This is a remarkable finding, since it 
demonstrates a clear difference between the POMC neu- 
rons and other neurons in the arcuate nucleus in terms of 
time of origin. This finding is further supported by immu- 
nocytochemical observations of peptide immunoreactivity 
very early in arcuate POMC neurons, i.e., days E12-E13.5 
(Schwartzberg and Nakane, '82; Khachaturian et al., '83a; 
Daikoku et  al., '83). This discrepancy can perhaps be ex- 
plained by the fact that  POMC neurons compose a minor 
portion of the total number of neurons in the arcuate nu- 
cleus, such that their numbers might not make a statisti- 
cally significant contribution to the labelling pattern seen 
when considering the entire neuronal population of this 
nucleus. A similar observation has been made by Hoffman 
et al. ('80), who have noted that somatostatin-containing 
neurons in the periventricular nucleus arise earlier than 
many of the other neurons in the same region. 
In conclusion, it is apparent that  a general, yet not precise 
correspondence exists between the patterns of opioid neu- 
ron generation and those patterns noted for whole hypotha- 
lamic nuclei in which the opioid neurons reside. The 
observation that the percentage of labelled opioid neurons 
at any particular day (or period of 2-3 days) is lower than 
those percentages obtained by Altman and Bayer ('78a) for 
the same time period is due to the fact that in the latter 
study, VjHlthymidine injections were made on 2 consecutive 
days, thus increasing the I3H]thymidine exposure time. 
TABLE 1. Comparison Between the Time of Neuron Origin Determined lor Each Nucleus by Altman and Bayer ('78a). 
and for Identified Opioid Neurons in the Present Study' 
Percentage cells born at each embryonic day 
E 16 
~~ 
Category Nucleus Study El2 El3 E 14 E 15 
- - Class 1 LHA Whole region 50 20 10 
(earliest Dynorphin 33 23 7 1.8 - 
arising) Enkephalin (PF) 17 9 3 
(early Dynorphin 28 39 19 4 4 
- - 
- - Class 2 SON Whole nucleus 35 31 30 
arising) PVN Whole nucleus 18 35 38 - - 
- Dynorphin 28 33 26 6 
- I'OA Medial part 20 25 45 5 
Enkephalin 7 15 23 9 1 
PV - Data not available 
Enkephalin 












14 24 19 18 
- 9 77 - 





ARC Middie level 15 10 45 20 10 
ACTH 29 24 23 9 2 
'Dab  on opioid neurons is taken from the histograms shown rn Figures 2-10, while whole nuclear data have been approximated from Altman and Bayer 1'78a). ARC, arcuate 
nucleus; LHA. lateral hypothalamic area, MM, medial mammillary nucleus; POA. preoptic area; PF. perifumlcal cells: PV, periventricular nucleus; PVN. paraventricular 
nucleus; SON, supraoptic nucleus; VM, ventromedial nucleus 
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Based on the present findings as well as those of Hoffman 
et al. ('801, it is apparent that  precise determinations of 
birthdates of chemically identified neurons can only be 
accomplished by combined immunocytochemical and [3H] 
thymidine autoradiographic studies, and cannot simply be 
inferred by extrapolation from whole nuclear studies. Ob- 
viously, birth-dating nuclei that  are made up of one type of 
cell, e.g., the magnocellular portions of supraoptic and par- 
aventricular nuclei, as well as the locus coeruleus (Lauder 
and Bloom, '741, is not a major problem. Conversely, the 
finding of early POMC neuron birth as well as early POMC 
peptide synthesis in a small subpopulation of arcuate neu- 
rons (Khachaturian et  al., '83a) indicates the need for such 
combined analyses. 
The early development of biosynthetically active POMC 
neurons may indicate an  important role for POMC peptides 
during a stage of development in which other peptides have 
not yet appeared. POMC products, especially a-MSH, have 
been shown to stimulate nerve cell maturation, perhaps 
being one of the more important neurotrophic factors dur- 
ing embryogenesis (see Swaab and Ter Borg, '81). The pres- 
ent findings appear to be consistent with this hypothesis. 
Furthermore, the finding that neither enkephalin nor dy- 
norphin neurons appear to arise at precisely the same time 
indicates that  neuron genesis in different regions of the 
hypothalamus proceeds according to specific timetables, in- 
fluenced by regulatory mechanisms which apparently work 
irrespective of the peptide product. 
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